复星国际2024年收入1921亿元,海外收入占比近半,医药全球化运营加速

IPO早知道
02 Apr

全球化运营体系实现产品价值最大化。本文为IPO早知道原创作者|罗宾微信公众号|ipozaozhidao据IPO早知道消息,复星国际(0656.HK)于近日发布了2024年全年业绩。2024年总收入录得人民币1921.4亿元;产业运营利润49亿元;四大核心子公司,包括豫园股份、复星医药、复星葡萄牙保险和复星旅文总收入达1346.5亿元,占集团总收入的比重达70.1%;总债务占总资本比率为52%;现金...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10